Nurix Therapeutics, Inc. (NRIX)
15.48
-0.89
(-5.44%)
USD |
NASDAQ |
Jun 03, 16:00
15.48
0.00 (0.00%)
After-Hours: 07:38
Nurix Therapeutics Shareholders Equity (Quarterly) : 480.89M for Feb. 28, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -236.00M |
| Alpha Cognition, Inc. | 57.46M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 636.13M |
| Total Liabilities (Quarterly) | 155.24M |
| Debt to Equity Ratio | 0.122 |
| Current Ratio | 6.013 |
| Net Debt Paydown Yield | -0.37% |